Cryo nerve block for pain after minimally invasive lung surgery
Official title: A Randomized Controlled Trial Studying the Effect of Additional Intercostal Cryo-analgesia (ICCA) to Standard Postoperative Pain Management in Patients Undergoing Minimally Invasive Lung Surgery
Run by St. Antonius Hospital · NCT06861387 · Data updated 2026-11-12
This study will test whether freezing the intercostal nerves during minimally invasive lung surgery reduces pain and opioid use for adults having VATS or RATS lung resections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | St. Antonius Hospital Academic / other |
| Locations | 1 site (Nieuwegein, Utrecht) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | July 1, 2028 |
| Study ends | December 12, 2029 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT06861387 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are electively scheduled for minimally invasive anatomical lung resection (VATS or RATS) and can give informed consent are eligible.
✕Probably not a fit
Patients on long-term opioids, with liver failure restricting acetaminophen use, connective tissue disease, pregnancy, or other contraindications to ICCA may not receive benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study examines intercostal cryo-analgesia (ICCA), a technique that uses controlled cold to temporarily reduce nerve activity, as an addition to multimodal pain management for patients undergoing minimally invasive anatomic lung resections. Participants undergoing VATS or RATS lobectomy, segmentectomy, or pneumonectomy will receive ICCA plus standard multimodal analgesia and outcomes will be compared with those receiving standard multimodal analgesia alone. Primary outcomes include postoperative pain scores, opioid consumption, and measures of recovery and hospital stay. The trial aims to provide higher-quality comparative data than the small observational studies done so far.
Why it matters
Potential benefit: If successful, ICCA could reduce postoperative pain and opioid requirements and help patients recover faster after minimally invasive lung resection.
How similar studies have gone: Small observational studies and case series have suggested benefit from ICCA in reducing pain and opioid use, but randomized controlled data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients are at least 18 years or older. 2. Patients are electively scheduled to undergo minimally invasive (i.e., VATS or RATS) anatomical lung (i.e., pneumonectomy, (bi)lobectomy, or segmentectomy) resection for benign or malignant disease. 3. Proficient understanding of the consequences of enrolment by the patients. 4. Written informed consent by the patient. Exclusion Criteria: 1. Patients with reported intolerance or hypersensitivity to the anaesthetic drug used for ICNB. 2. Patients chronically using opioids for reasons not related to the operation (i.e., more than 3 months). 3. Patients with liver failure inhibiting the systematic use of acetaminophen (i.e., paracetamol) 4. Patients with connective tissue disease. 5. Patients with comorbidities or history contra-indicating ICCA. 6. Patients who are pregnant. 7. Participation in other clinical trial(s) that may interfere with the current trial.
Where it's running
-
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, Netherlands Recruiting
Study contacts
- Study coordinator: Bart Köhlen
- Email: b.kohlen@antoniusziekenhuis.nl
- Phone: +31 88 320 1108
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term safety follow-up after freezing nerves to help pain after chest surgery
This study follow-ups patients who had percutaneous cryoneurolysis to help pain after Nuss procedure for pectus excavatum and checks their pain, nerve sensations, and quality of life over up to 24 months.
-
Erector spinae plane block versus thoracoscopic intercostal nerve block for pain after VATS lung surgery
This compares two nerve-block techniques to see which gives better pain control after elective VATS lung surgery in adults.
-
Tracking nerve-freezing during limb amputation to learn about post-operative and phantom limb pain
This registry will track how freezing nerves (cryoablation) is used during limb amputations to see if it affects post-operative and phantom limb pain in adults who have or will have an amputation.
-
Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy
This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.
-
Robot-assisted versus open lateral pancreaticojejunostomy for symptomatic chronic pancreatitis
This trial will test whether robot-assisted or open lateral pancreaticojejunostomy leads to better early recovery for adults with chronic pancreatitis and a dilated main pancreatic duct.
-
Laparoscopic versus robot-assisted left-sided pancreas removal for benign and premalignant lesions
This trial will randomize adults needing elective left-sided pancreas removal for benign or premalignant lesions to laparoscopic or robot-assisted minimally invasive surgery to see if one approach leads to faster recovery and fewer complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.